THE EXPECTED IMPACT OF MANAGED HEALTH ORGANIZATIONS ON U.S.-BASED PHARMACEUTICAL PRODUCT DEVELOPMENT AND MARKETING

Authors: Office of the Actuary, Health Care Financing Administration Division of Cost Estimates
Doering P.L.
Levit K.R.
Publication date
Publisher: 'Wiley'
Doi

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Crossref

redirect

Last time updated on 27/11/2020